Bottom line
HIBS vs METD: the short answer
HIBS (Direxion Daily S&P 500(R) High Beta Bear 3X ETF) and METD (Direxion Daily META Bear 1X ETF) are both etfs.
METD is cheaper at 1.02% vs 1.06% — a difference of $4.00 a year per $10,000 invested.
Over one year, METD returned −17.3% vs −72.4% for HIBS.
Updated Nov 19, 2026
HIBS vs METD side by side
| HIBS | METD | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Direxion | Direxion |
| Category | Leveraged & Inverse | Leveraged & Inverse |
| Expense ratio | 1.06% | 1.02% |
| Annual cost per $10k | $106 | $102 |
| 10-yr cost on $10k (prospectus) | $1,347 | $1,428 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | −72.4% | −17.3% |
| 5-yr return (annualized) | −55.6% | — |
| 10-yr return (annualized) | — | — |
| Best quarter | +74.7% | +10.1% |
| Worst quarter | −79.0% | −25.5% |
| Net assets (fund) | $22.6M | $10.8M |
| Number of holdings | 8 | 8 |
| Portfolio turnover | % | % |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | HIBS | METD | Difference |
|---|---|---|---|
| 2025 | −72.4% | −17.3% | −55.1% |
Source: Fund prospectus bar charts
Holdings overlap
8 of HIBS's top 8 holdings also appear in METD's top 8.
| Holding | HIBS | METD |
|---|---|---|
| Dreyfus | 48.43% | 67.68% |
| Goldman Financial | 28.96% | 17.87% |
| Goldman Sachs Liq Es Fd A | 26.65% | 12.14% |
| N/a | 5.90% | 1.07% |
| N/a | 2.40% | 1.07% |
| N/a | 2.21% | 1.07% |
| N/a | 1.19% | 1.07% |
| N/a | 1.18% | 1.07% |
Source: SEC Form N-PORT
HIBS top 10
- Dreyfus — 48.43%
- Goldman Financial — 28.96%
- Goldman Sachs Liq Es Fd A — 26.65%
- N/a — 5.90%
- N/a — 2.40%
- N/a — 2.21%
- N/a — 1.19%
- N/a — 1.18%
METD top 10
- Dreyfus — 67.68%
- Goldman Financial — 17.87%
- Goldman Sachs Liq Es Fd A — 12.14%
- Dreyfus — 3.99%
- N/a — 3.73%
- N/a — 2.57%
- N/a — 2.23%
- N/a — 1.07%
FAQ
What is the difference between HIBS and METD?
Which is cheaper, HIBS or METD?
Should I own both HIBS and METD?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.